Hereditary ovarian cancer

A clinicopathological study

Chhanda D. Bewtra, Patrice Watson, Teresa Conway, Connie Read-Hippee, Henry T. Lynch

Research output: Contribution to journalArticle

103 Citations (Scopus)

Abstract

Hereditary ovarian cancer (HOC) is rare and little recognized. Over the years, we have identified 37 HOC patients from HOC syndrome kindreds with documented cancers of ovary, breast, colon, or endometrium in two or more first-degree relatives. The age and clinical stage at diagnosis and overall 5-year survival of HOC patients were compared with those of ovarian cancers in the unselected patients. The gross and microscopic features of the tumors are compared with a set of 34 consecutively chosen ovarian cancer cases with documented negative family histories. The mean age of HOC patients at diagnosis was significantly lower (50.2 years) than that of the unselected control population (59 years) (p <0.001). Detailed pedigree analysis breaks down the HOC group into (a) site-specific ovarian cancer, 5 cases, 56.4 years mean age; (b) breast-ovarian cancer syndrome, 28 cases, 50.46 years mean age; and (c) Lynch syndrome II (colon/endometrial cancer), 4 cases, mean age 41 years. The age differences were statistically significant (p = 0.050). The most prevalent International Federation of Gynecology and Obstetrics clinical stage at diagnosis of HOC (stage III) was the same as for the control group. Histologically, all (100%) HOC tumors were surface epithelial cancers with predominance of serous papillary type moderate to high grade (89 versus 71% in control, p = 0.07). No other pathologic features appeared to be significant. In conclusion, HOC is a serous papillary tumor and characterized by early age of onset and excess of breast/ovary/colon-endometrial cancers in first-degree relatives of patients with specific HOC syndromes.

Original languageEnglish
Pages (from-to)180-187
Number of pages8
JournalInternational Journal of Gynecological Pathology
Volume11
Issue number3
StatePublished - 1992

Fingerprint

Ovarian Neoplasms
Hereditary Neoplastic Syndromes
Endometrial Neoplasms
Colonic Neoplasms
Lynch Syndrome II
Neoplasms
Breast Neoplasms
Pedigree
Endometrium
Gynecology
Age of Onset
Obstetrics
Ovary
Colon
Breast

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynecology
  • Pathology and Forensic Medicine

Cite this

Bewtra, C. D., Watson, P., Conway, T., Read-Hippee, C., & Lynch, H. T. (1992). Hereditary ovarian cancer: A clinicopathological study. International Journal of Gynecological Pathology, 11(3), 180-187.

Hereditary ovarian cancer : A clinicopathological study. / Bewtra, Chhanda D.; Watson, Patrice; Conway, Teresa; Read-Hippee, Connie; Lynch, Henry T.

In: International Journal of Gynecological Pathology, Vol. 11, No. 3, 1992, p. 180-187.

Research output: Contribution to journalArticle

Bewtra, CD, Watson, P, Conway, T, Read-Hippee, C & Lynch, HT 1992, 'Hereditary ovarian cancer: A clinicopathological study', International Journal of Gynecological Pathology, vol. 11, no. 3, pp. 180-187.
Bewtra, Chhanda D. ; Watson, Patrice ; Conway, Teresa ; Read-Hippee, Connie ; Lynch, Henry T. / Hereditary ovarian cancer : A clinicopathological study. In: International Journal of Gynecological Pathology. 1992 ; Vol. 11, No. 3. pp. 180-187.
@article{167f1bd27f944c9592f20ab5e3812e4c,
title = "Hereditary ovarian cancer: A clinicopathological study",
abstract = "Hereditary ovarian cancer (HOC) is rare and little recognized. Over the years, we have identified 37 HOC patients from HOC syndrome kindreds with documented cancers of ovary, breast, colon, or endometrium in two or more first-degree relatives. The age and clinical stage at diagnosis and overall 5-year survival of HOC patients were compared with those of ovarian cancers in the unselected patients. The gross and microscopic features of the tumors are compared with a set of 34 consecutively chosen ovarian cancer cases with documented negative family histories. The mean age of HOC patients at diagnosis was significantly lower (50.2 years) than that of the unselected control population (59 years) (p <0.001). Detailed pedigree analysis breaks down the HOC group into (a) site-specific ovarian cancer, 5 cases, 56.4 years mean age; (b) breast-ovarian cancer syndrome, 28 cases, 50.46 years mean age; and (c) Lynch syndrome II (colon/endometrial cancer), 4 cases, mean age 41 years. The age differences were statistically significant (p = 0.050). The most prevalent International Federation of Gynecology and Obstetrics clinical stage at diagnosis of HOC (stage III) was the same as for the control group. Histologically, all (100{\%}) HOC tumors were surface epithelial cancers with predominance of serous papillary type moderate to high grade (89 versus 71{\%} in control, p = 0.07). No other pathologic features appeared to be significant. In conclusion, HOC is a serous papillary tumor and characterized by early age of onset and excess of breast/ovary/colon-endometrial cancers in first-degree relatives of patients with specific HOC syndromes.",
author = "Bewtra, {Chhanda D.} and Patrice Watson and Teresa Conway and Connie Read-Hippee and Lynch, {Henry T.}",
year = "1992",
language = "English",
volume = "11",
pages = "180--187",
journal = "International Journal of Gynecological Pathology",
issn = "0277-1691",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Hereditary ovarian cancer

T2 - A clinicopathological study

AU - Bewtra, Chhanda D.

AU - Watson, Patrice

AU - Conway, Teresa

AU - Read-Hippee, Connie

AU - Lynch, Henry T.

PY - 1992

Y1 - 1992

N2 - Hereditary ovarian cancer (HOC) is rare and little recognized. Over the years, we have identified 37 HOC patients from HOC syndrome kindreds with documented cancers of ovary, breast, colon, or endometrium in two or more first-degree relatives. The age and clinical stage at diagnosis and overall 5-year survival of HOC patients were compared with those of ovarian cancers in the unselected patients. The gross and microscopic features of the tumors are compared with a set of 34 consecutively chosen ovarian cancer cases with documented negative family histories. The mean age of HOC patients at diagnosis was significantly lower (50.2 years) than that of the unselected control population (59 years) (p <0.001). Detailed pedigree analysis breaks down the HOC group into (a) site-specific ovarian cancer, 5 cases, 56.4 years mean age; (b) breast-ovarian cancer syndrome, 28 cases, 50.46 years mean age; and (c) Lynch syndrome II (colon/endometrial cancer), 4 cases, mean age 41 years. The age differences were statistically significant (p = 0.050). The most prevalent International Federation of Gynecology and Obstetrics clinical stage at diagnosis of HOC (stage III) was the same as for the control group. Histologically, all (100%) HOC tumors were surface epithelial cancers with predominance of serous papillary type moderate to high grade (89 versus 71% in control, p = 0.07). No other pathologic features appeared to be significant. In conclusion, HOC is a serous papillary tumor and characterized by early age of onset and excess of breast/ovary/colon-endometrial cancers in first-degree relatives of patients with specific HOC syndromes.

AB - Hereditary ovarian cancer (HOC) is rare and little recognized. Over the years, we have identified 37 HOC patients from HOC syndrome kindreds with documented cancers of ovary, breast, colon, or endometrium in two or more first-degree relatives. The age and clinical stage at diagnosis and overall 5-year survival of HOC patients were compared with those of ovarian cancers in the unselected patients. The gross and microscopic features of the tumors are compared with a set of 34 consecutively chosen ovarian cancer cases with documented negative family histories. The mean age of HOC patients at diagnosis was significantly lower (50.2 years) than that of the unselected control population (59 years) (p <0.001). Detailed pedigree analysis breaks down the HOC group into (a) site-specific ovarian cancer, 5 cases, 56.4 years mean age; (b) breast-ovarian cancer syndrome, 28 cases, 50.46 years mean age; and (c) Lynch syndrome II (colon/endometrial cancer), 4 cases, mean age 41 years. The age differences were statistically significant (p = 0.050). The most prevalent International Federation of Gynecology and Obstetrics clinical stage at diagnosis of HOC (stage III) was the same as for the control group. Histologically, all (100%) HOC tumors were surface epithelial cancers with predominance of serous papillary type moderate to high grade (89 versus 71% in control, p = 0.07). No other pathologic features appeared to be significant. In conclusion, HOC is a serous papillary tumor and characterized by early age of onset and excess of breast/ovary/colon-endometrial cancers in first-degree relatives of patients with specific HOC syndromes.

UR - http://www.scopus.com/inward/record.url?scp=0026663495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026663495&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 180

EP - 187

JO - International Journal of Gynecological Pathology

JF - International Journal of Gynecological Pathology

SN - 0277-1691

IS - 3

ER -